These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15527229)

  • 21. Hemoglobin A1c values and CGM.
    Blevins T
    Diabetes Technol Ther; 2012 Oct; 14(10):971; author reply 972. PubMed ID: 23013204
    [No Abstract]   [Full Text] [Related]  

  • 22. 5(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, May 3-5, 2012, Dublin, Ireland.
    Hoey H; Mlinac A; Tran CT; Schlaeger C
    Diabetes Technol Ther; 2012 Dec; 14(12):1155-73. PubMed ID: 23216339
    [No Abstract]   [Full Text] [Related]  

  • 23. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review.
    Polinski JM; Connolly JG; Curtis BH; Seeger JD; Gaskins K; Perez M; Smith BF; Shrank WH
    Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment by external insulin pump].
    Clavel S
    Soins; 2010 Dec; (751):22, 24-6, 28-9. PubMed ID: 21298936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review.
    Khunti K; Millar-Jones D
    Prim Care Diabetes; 2017 Feb; 11(1):3-12. PubMed ID: 27727005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial.
    Cohen D; Weintrob N; Benzaquen H; Galatzer A; Fayman G; Phillip M
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1047-50. PubMed ID: 14513883
    [No Abstract]   [Full Text] [Related]  

  • 27. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.
    Rodriguez-Gutierrez R; Lipska KJ; McCoy RG
    JAMA Intern Med; 2016 Mar; 176(3):300-1. PubMed ID: 26882223
    [No Abstract]   [Full Text] [Related]  

  • 28. When and how to implement basal-bolus therapy: treating to success.
    White RD
    J Fam Pract; 2009 Aug; 58(8 Suppl):S18-24. PubMed ID: 19679027
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy.
    Lopez CA; Kanna B
    Arch Intern Med; 2008 Mar; 168(5):548. PubMed ID: 18332304
    [No Abstract]   [Full Text] [Related]  

  • 30. Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.
    Shanik MH
    Diabetes Technol Ther; 2012 Jun; 14(6):533-9. PubMed ID: 22364142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 32. [Certain beginning of insulin therapy: yes, we can, but...].
    Rohrer A
    Praxis (Bern 1994); 2009 Mar; 98(6):301. PubMed ID: 19338117
    [No Abstract]   [Full Text] [Related]  

  • 33. Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.
    Bretzel RG; Eckhard M; Landgraf W; Owens DR; Linn T
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S260-5. PubMed ID: 19875561
    [No Abstract]   [Full Text] [Related]  

  • 34. [Researchers illuminate diabetes therapy].
    Pflege Z; 2014 Feb; 67(2):126. PubMed ID: 24730335
    [No Abstract]   [Full Text] [Related]  

  • 35. [When tablets are no longer enough. Which insulin for type 2 diabetic patients?].
    MMW Fortschr Med; 2002 Sep; 144(38):58. PubMed ID: 12395711
    [No Abstract]   [Full Text] [Related]  

  • 36. Overcoming barriers to insulin replacement.
    Kuritzky L
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract]   [Full Text] [Related]  

  • 37. Summaries for patients. Inhaled insulin with or instead of oral medications for type 2 diabetes.
    Ann Intern Med; 2005 Oct; 143(8):I28. PubMed ID: 16230717
    [No Abstract]   [Full Text] [Related]  

  • 38. [Insulin glargine. The most studied basal insulin].
    Walter M
    MMW Fortschr Med; 2013 Nov; 155(19):70-1. PubMed ID: 24475676
    [No Abstract]   [Full Text] [Related]  

  • 39. Course of glycaemia in poorly controlled type 2 diabetes patients 2.5 years after optimizing oral treatment in general practice.
    Berghout LM; Gorter KJ; Rutten GE
    Eur J Gen Pract; 2006; 12(2):80-2. PubMed ID: 16945883
    [No Abstract]   [Full Text] [Related]  

  • 40. [Supplemental insulin therapy of type 2 diabetes follows the example of nature. Replace what the patient lacks].
    MMW Fortschr Med; 2004 May; 146(22):47. PubMed ID: 15373112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.